AACR presents award to pediatric cancer ‘dream team’
Click Here to Manage Email Alerts
American Association for Cancer Research presented its AACR Team Science Award to the St. Baldrick’s Foundation-Stand Up To Cancer Pediatric Cancer Dream Team.
The award recognizes an outstanding interdisciplinary team of researchers for innovative and meritorious science that has advanced or may advance fundamental knowledge of cancer, or a team that applied existing knowledge to advancing cancer prevention, detection, diagnosis or treatment.
St. Baldrick’s Foundation and Stand Up To Cancer (SU2C) collaborated in 2013 to create a pediatric cancer dream team charged with developing new immunotherapy approaches for high-risk childhood cancers. The team consists of about 200 researchers from 10 children’s hospitals and childhood cancer-focused research programs.
Team co-leaders are John M. Maris, MD, chair in neuroblastoma research at The Children’s Hospital of Philadelphia and professor of pediatrics at Perelman School of Medicine at University of Pennsylvania, and Crystal L. Mackall, MD, professor of pediatrics and professor of medicine at Stanford University School of Medicine, co-executive director of Stanford Laboratory for Cell and Gene Medicine, founding director of Stanford Center for Cancer Cell Therapy, associate director of Stanford Cancer Institute, leader of the cancer immunology and immunotherapy program, and director of Parker Institute for Cancer Immunotherapy at Stanford.
The collaboration has resulted in more than $118 million in additional grant funding, the creation of a new pediatric clinical trials network, treatment of more than 1,100 children through early clinical trials, and the publication of 319 peer-reviewed manuscripts.
“From establishing novel immunotherapies for pediatric cancer, to giving hope to thousands of children and their families through the clinical trial network it established, the St. Baldrick’s Foundation-SU2C Pediatric Cancer Dream Team has made incredible advancements in pediatric cancer research,” Margaret Foti, PhD, MD (hc), CEO of AACR, said in an association-issued press release.
Click Here to Manage Email Alerts